• Login
    View Item 
    •   DSpace@RPI Home
    • Rensselaer Libraries
    • RPI Theses Online (Complete)
    • View Item
    •   DSpace@RPI Home
    • Rensselaer Libraries
    • RPI Theses Online (Complete)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Multivalent bioconjugates for the inhibition of anthrax toxin, influenza virus, and HIV

    Author
    Martin, Jacob T.
    View/Open
    172784_Martin_rpi_0185E_10357.pdf (5.415Mb)
    172785_2014-05-09Dissertation-JacobTMartin-SupplementalInformation.pdf (590.6Kb)
    Other Contributors
    Kane, Ravi S.; Tessier, Peter M.; Cramer, Steven M.; Garde, Shekhar; Belfort, Marlene, 1945-;
    Date Issued
    2014-05
    Subject
    Chemical and biological engineering
    Degree
    PhD;
    Terms of Use
    This electronic version is a licensed copy owned by Rensselaer Polytechnic Institute, Troy, NY. Copyright of original work retained by author.;
    Metadata
    Show full item record
    URI
    https://hdl.handle.net/20.500.13015/1147
    Abstract
    Here I describe the structure-based design of macromolecular bioconjugates for the effective inhibition of three different diseases with broad public interest: anthrax, influenza, and HIV/AIDS. To that end, I have synthesized multivalent arrangements of bioactive macromolecules (i.e., peptides, proteins, and oligonucleotides) on biocompatible scaffolds in order to enhance the inhibitory efficacy of those biomolecules. Multivalency is the simultaneous interaction of multiple binding elements with multiple target receptors, and this phenomenon underlies a powerful strategy for controlling the potency of bioactive molecules by manipulating their context. For example, some multivalent ligand-receptor interactions are known to exhibit binding avidities that are several orders of magnitude stronger than the corresponding monovalent receptor-ligand binding affinities. An important aspect of this research was the identification of appropriate targets from the etiology of each of these diseases. Once suitable targets were identified, I used strategically-chosen scaffolds to control the multivalent arrangements of targeting ligands. Specifically, the anthrax toxin protective antigen heptamer was the target of multivalent anti-toxin inhibitors that display peptide ligands on either linear or radial scaffolds. Similarly, a conserved region of the influenza hemagglutinin glycoprotein was targeted by a series of linear divalent and polyvalent cell entry inhibitors. Finally, a recently-identified protein ligand for CCR5, a co-receptor for HIV cell attachment and entry, was used for polyvalent display on linear polymer scaffolds, and the ability to obstruct CCR5 binding was shown. The results support the potential for multivalent bioconjugates such as these to lead to very promising therapeutic applications.;
    Description
    May 2014; School of Engineering
    Department
    Dept. of Chemical and Biological Engineering;
    Publisher
    Rensselaer Polytechnic Institute, Troy, NY
    Relationships
    Rensselaer Theses and Dissertations Online Collection;
    Access
    Restricted to current Rensselaer faculty, staff and students. Access inquiries may be directed to the Rensselaer Libraries.;
    Collections
    • RPI Theses Online (Complete)

    Browse

    All of DSpace@RPICommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    DSpace software copyright © 2002-2022  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV